Statistics
Publications
24
Citations
2.6K
H-Index
21
Active since
2002
Zhiyong Ding is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.
Publications per year
2002–2022
24
24
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
Lijun Zhou, Mingli Sun, Xian Zhang et al. · Oncogene · 2015 · 393 citations
Medicine, Oncology, Pharmacology +12
Vimentin is a novel AKT1 target mediating motility and invasion
Zhu Qs, Kevin P. Rosenblatt, Guy Lahat et al. · Oncogene · 2010 · 247 citations
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas
Lan V. Pham, Shengjian Huang, Hui Zhang et al. · Clinical Cancer Research · 2018 · 104 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 24